Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | President & COO | September 29, 2016 | October 03, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date September 29, 2016 · Filed October 03, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.95 · Expires 2021-10-29 | Direct | 50,000 |
Reported balance
After 2016-09-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2016-09-29 · Grant · Acquired 20,000 · Balance 50,000 F1: Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the five anniversary dates of the grant |
Filing footnotes · ownership attribution and instrument terms
F1: Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the five anniversary dates of the grant
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2016 Filed Oct 3, 2016 23:06 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $53.95 | $0.00 |
DisclosureSEC source: 0000711377-16-000091 · primary_doc.xml · derivative · entry 1 CALK RICHARD E JR · CIK 0001627465 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 20,000 shares Expires 2021-10-29 F1 · derivative.exercise_date: Options were granted 9/29/2016, have five year lives, and vest in equal 20% annual installments on each of the five anniversary dates of the grant Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.